Stromal-cell deletion of STAT3 protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration
A. K. Ajay, L. Zhao, S. Vig, M. Fujiwara, S. Thakurela, S. Jadhav, I.-J. Chiu, Y. Ding, K. K. Ramachandran, A. Mittal, A. Bhatt, P. Chaluvadi, M. K. Gupta, V. S. Sabbisetti, A. M. Waaga-Gasser, M. Gopal, D. A. Frank, J. V. Bonventre, L.-L. Hsiao
Abstract
Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor implicated in the pathogenesis of kidney fibrosis. Although tubular Stat3 deletion in tubular epithelial cells is known to protect mice from kidney fibrosis, the exact function of STAT3 in stromal cells remains unknown. We utilized stromal-cell Stat3 knock-out (KO) mice, CRISPR and pharmacologic activators and inhibitors of STAT3 to investigate its function in pericyte-like cells. STAT3 is phosphorylated in tubular epithelial cells in acute kidney injury whereas its activation expanded to interstitial cells in chronic kidney disease in mice and humans. Stromal cell-specific deletion of Stat3 protects mice from folic acid- and aristolochic acid-induced kidney fibrosis. Mechanistically, STAT3 directly regulates the inflammatory pathway, differentiation of pericytes into myofibroblasts. Specifically, STAT3 activation leads to an increase in migration and profibrotic signaling in genome-edited pericyte-like cells, 10T1/2. Conversely, Stat3 KO or blocking STAT3 function inhibits detachment, spreading, migration, and profibrotic signaling. Furthermore, STAT3 binds to Collagen1a1 promoter of fibrotic mouse kidneys and in pericyte-like cells. Together, our study identifies a previously unknown function of STAT3 in stromal cells that promotes kidney fibrosis and may have therapeutic value in fibrotic kidney disease. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=73 SRC="FIGDIR/small/456872v1_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@35dcbforg.highwire.dtl.DTLVardef@2fc055org.highwire.dtl.DTLVardef@fc0d92org.highwire.dtl.DTLVardef@1def2e6_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SOX9 is required for kidney fibrosis and regulates NAV3 to control renal myofibroblast function in mice and humans
S. Raza, E. Jokl, … K. Piper Hanley·bioRxiv·Nov 12, 2019
- Tubular STAT3 limits renal inflammation in autosomal dominant polycystic kidney disease
A. Viau, M. Baziz, … F. Bienaime·Journal of the American Society of NephrologyPeer-reviewed·Apr 1, 2020
- The fibrocystin C-terminal domain inhibits Src/STAT3 signal induced cystogenesis of kidney epithelia.
Fatima Hassan, Susanne T. Hahnenstein, … Wolfgang H. Ziegler·bioRxiv·Aug 8, 2025
- Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys
S. P. Srivastava, J. Li, … D. Koya·bioRxiv·Dec 15, 2020
- Single-cell transcriptomic profiling of kidney fibrosis identifies a novel specific fibroblast marker and putative disease target
Valeria Rudman-Melnick, Mike Adam, … Prasad Devarajan·bioRxiv·Sep 13, 2022
- Inhibition of (interstitial) P2Y6 receptors attenuates renal fibrosis progression
Lena-Marie Süß, Anna Petzendorfer, … A. W. Forst·bioRxiv·Jan 29, 2026